Abstract
As the need for accurate diagnostic imaging often continues throughout a cancer survivor’s life, imaging methods with the least toxicity must be used so as to provide needed information without contributing to long-term sequelae that might compound toxicities inherent with the primary disease and its treatment. In this regard, the costs, benefits and potential risks of post-therapy monitoring for disease recurrence warrant periodic review. Unfortunately, few analyses are available regarding the impact of surveillance imaging on the detection of disease recurrence, salvage rates of relapse disease and long-term survival outcomes for pediatric cancer survivors. This review will examine the role and limitations of surveillance imaging in pediatric oncology.
Similar content being viewed by others
References
Mariotto AB, Rowland JH, Yabroff KR et al (2009) Long-term survivors of childhood cancers in the United States. Cancer Epidemiol Biomarkers Prev 18:1033–1040
Bhatia S, Yasui Y, Robison LL et al (2003) High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin’s disease: report from the Late Effects Study Group. J Clin Oncol 21:4386–4394
Bhatti P, Veiga LH, Ronckers CX et al (2010) Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res 174:741–752
Inskip PD, Curtis RE (2007) New malignancies following childhood cancer in the United States, 1973–2002. Int J Cancer 121:2233–2240
Reaman GH (2009) What, why, and when we image: considerations for diagnostic imaging and clinical research in the Children’s Oncology Group. Pediatr Radiol 39(Suppl 1):S42–S45
Meadows AT, Friedman DL, Neglia JP et al (2009) Second neoplasms in survivors of childhood cancer: findings from the childhood cancer survivor study cohort. J Clin Oncol 27:2356–2362
Bowers DC, Adhikari S, El-Khashab YM et al (2009) Survey of long-term follow-up programs in the United States for survivors of childhood brain tumors. Pediatr Blood Cancer 53:1295–1301
Minn AY, Pollock BH, Garzarella L et al (2001) Surveillance neuroimaging to detect relapse in childhood brain tumors: a pediatric oncology group study. J Clin Oncol 19:4135–4140
Lee AI, Zuckerman DS, Van den Abbeele AD et al (2010) Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis. Cancer 116:3835–3842
Postovsky S, Barzilai M, Meller I et al (2008) Does regular follow-up influence the survival of patients with sarcoma after recurrence? The Miri Shitrit pediatric oncology department experience. J Pediatr Hematol Oncol 30:189–195
Kovanlikaya A, Karabay N, Cakmakci H et al (2003) Surveillance imaging and cost effectivity in pediatric brain tumors. Eur J Radiol 47:188–192
Biasotti S, Garaventa A, Padovani P et al (2005) Role of active follow-up for early diagnosis of relapse after elective end of therapies. Pediatr Blood Cancer 45:781–786
Owens CM, Brisse HJ, Olsen OE et al (2008) Bilateral disease and new trends in Wilms tumour. Pediatr Radiol 38:30–39
Guadagnolo BA, Punglia RS, Kuntz KM et al (2006) Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin’s disease. J Clin Oncol 24:4116–4122
Torrey MJ, Poen JC, Hoppe RT (1997) Detection of relapse in early-stage Hodgkin’s disease: role of routine follow-up studies. J Clin Oncol 15:1123–1130
Dryver ET, Jernstrom H, Tompkins K et al (2003) Follow-up of patients with Hodgkin’s disease following curative treatment: the routine CT scan is of little value. Br J Cancer 89:482–486
Howell L, Mensah A, Brennan B et al (2005) Detection of recurrence in childhood solid tumors. Cancer 103:1274–1279
Chong AL, Grant RM, Ahmed BA et al (2010) Imaging in pediatric patients: time to think again about surveillance. Pediatr Blood Cancer 55:407–413
Nathan PC, Ness KK, Mahoney MC et al (2010) Screening and surveillance for second malignant neoplasms in adult survivors of childhood cancer: a report from the childhood cancer survivor study. Ann Intern Med 153:442–451
Meadows AT (2003) Pediatric cancer survivors: Past history and future challenges. Curr Probl Cancer 27:112–126
Hudson MM, Mulrooney DA, Bowers DC et al (2009) High-risk populations identified in childhood cancer survivor study investigations: implications for risk-based surveillance. J Clin Oncol 27:2405–2414
Kaste SC (2008) Skeletal toxicities of treatment in children with cancer. Pediatr Blood Cancer 50(2 Suppl):469–473
Karimova EJ, Rai SN, Ingle D et al (2006) MRI of knee osteonecrosis in children with leukemia and lymphoma: Part 2, clinical and imaging patterns. AJR 186:477–482
LA Mattano J, Sather HN, Trigg ME et al (2000) Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the children’s cancer group. J Clin Oncol 18:3262–3272
Sala A, Mattano LA Jr, Barr RD (2007) Osteonecrosis in children and adolescents with cancer—an adverse effect of systemic therapy. Eur J Cancer 43:683–689
Barr RD, Sala A (2008) Osteonecrosis in children and adolescents with cancer. Pediatr Blood Cancer 50(2 Suppl):483–485
Children’s Oncology Group (2008) Long-term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers. Available via www.survivorshipguidelines.org. Accessed 07 March 2011
Guppy AE, Tebbutt NC, Norman A et al (2003) The role of surveillance CT scans in patients with diffuse large B-cell non-Hodgkin’s lymphoma. Leuk Lymphoma 44:123–125
Elis A, Blickstein D, Klein O et al (2002) Detection of relapse in non-Hodgkin’s lymphoma: role of routine follow-up studies. Am J Hematol 69:41–44
de Graaf N, Hew JM, Fock JM et al (2002) Predictive value of clinical evaluation in the follow-up of children with a brain tumor. Med Pediatr Oncol 38:254–257
Ron E (2003) Cancer risks from medical radiation. Health Phys 85:47–59
Frush DP, Goske MJ, Hernanz-Schulman M (2008) Computed tomography and radiation exposure. N Engl J Med 358:851–853
Frush DP (2009) Radiation, CT, and children: the simple answer is … it’s complicated. Radiology 252:4–6
Brenner D, Elliston C, Hall E et al (2001) Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR 176:289–296
Huda W (2004) Assessment of the problem: pediatric doses in screen-film and digital radiography. Pediatr Radiol 34(Suppl 3):S173–S182
Huda W (2007) Radiation doses and risks in chest computed tomography examinations. Proc Am Thorac Soc 4:316–320
Brody AS, Frush DP, Huda W et al (2007) Radiation risk to children from computed tomography. Pediatrics 120:677–682
Girshin M, Shapiro V, Rhee A et al (2009) Increased risk of general anesthesia for high-risk patients undergoing magnetic resonance imaging. J Comput Assist Tomogr 33:312–315
Kwee TC, Takahara T, Luijten PR et al (2010) ADC measurements of lymph nodes: inter- and intra-observer reproducibility study and an overview of the literature. Eur J Radiol 75:215–220
Ley S, Ley-Zaporozhan J, Schenk JP (2009) Whole-body MRI in the pediatric patient. Eur J Radiol 70:442–451
Darge K, Jaramillo D, Siegel MJ (2008) Whole-body MRI in children: current status and future applications. Eur J Radiol 68:289–298
Acknowledgement
We thank Ms. Sandra Gaither for manuscript preparation.
Disclaimer
The supplement this article is part of is not sponsored by the industry. Dr. Kaste discloses that this work is supported in part by grants P30 CA-21765 from the National Institutes of Health, a Center of Excellence grant from the State of Tennessee, and the American Lebanese Syrian Associated Charities (ALSAC).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaste, S.C. Oncological imaging: tumor surveillance in children. Pediatr Radiol 41 (Suppl 2), 505 (2011). https://doi.org/10.1007/s00247-011-2108-1
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00247-011-2108-1